Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at UiPath (NYSE:PATH) and the best and worst ...

UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

UiPath (PATH) stock analysis: accelerating revenue and ARR near $2B with strong margins. Read the full analysis here.

UiPath operates in enterprise software as automation, artificial intelligence, and digital workflows continue shaping ...

Together, UiPath and Deloitte will help organizations accelerate testing with agentic AI for enhanced resilience and innovation, enabling continuous autonomous quality UiPath (NYSE: PATH), a leader in ...

First, let's talk about why UiPath struggled so much during 2024. Its primary business is software for robotic process automation (RPA), which is used for automating repetitive tasks, such as an ...

Every technology company wants a slice of the Artificial Intelligence (AI) pie. More accurately, every tech company wants to show that it has a healthy AI development stream bringing the benefits of ...

UiPath Inc. (NYSE:PATH) is one of the best long term stocks to buy under $20. BMO Capital cut the price target on UiPath Inc.

Both Palantir Technologies Inc. PLTR and UiPath Inc. PATH are prominent companies at the forefront of AI-centric software innovation. Palantir is renowned for its expertise in large-scale data ...

UiPath, Inc. (NYSE:PATH) has fallen more than 28.5% on a year-to-date basis, and the stock’s short float has exceeded 30%, ...

PENRYN, ENGLAND - MAY 09: Engineered Arts prosthetic expert Mike Humphrey checks on Fred a recently completed Mesmer robot that was built at the company's headquarters in Penryn on May 9, 2018 in ...